Filbrandt Wealth Management’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Filbrandt Wealth Management’s Portfolio ZEAL Stock Details ZEAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-25	Closed	-$1K	–	476
2020 Q1	$1K	Buy	+25	New	+$871	﹤0.01%	237

Other funds holding ZEAL

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IBT

International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Filbrandt Wealth Management's ZEAL Position: Q2 2020 in Review

Filbrandt Wealth Management sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q2 2020, closing a stake of 25 shares — an estimated $1K sold.

Filbrandt Wealth Management first reported a position in ZEAL in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 16 funds tracked by Wall St. Rank hold ZEAL as of Q2 2020.

Filbrandt Wealth Management reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q2 2020 after selling out during the quarter.
Filbrandt Wealth Management sold 25 Zealand Pharma A/S American Depositary Shares shares in Q2 2020, an estimated $1K.
Filbrandt Wealth Management first reported a position in Zealand Pharma A/S American Depositary Shares in Q1 2020 and held it in 1 quarter.
Filbrandt Wealth Management's Zealand Pharma A/S American Depositary Shares position peaked at $1K in Q1 2020.
16 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q2 2020.

Based on Filbrandt Wealth Management's 13F filing for Q2 2020, filed 11 Aug 2020.